Background: Current guidelines for septic shock management recommend administration of appropriate, broad-spectrum antimicrobials within 1 hour of recognition. Objective: To evaluate the interventions pharmacists make as part of a sepsis response team and to determine if these interventions increase the proportion of patients with appropriate empiric antimicrobial therapy. Methods: A retrospective cohort study was undertaken reviewing adult patients in a large, academic medical center with confirmed septic shock who had an order for a "sepsis bundle," which includes notification of a pharmacist to assess adequacy of empiric therapy. Pharmacist interventions with regard to selection of empiric antimicrobials were documented. The proportion of patients with initial successful selection of antimicrobial therapy (SSAT) before and after pharmacist intervention was assessed as well as the time to first antimicrobial administration and time to appropriate antimicrobial administration. Results: A total of 76 patients were included. Pharmacist intervention increased the proportion of patients with SSAT from 66% to 80% (P ¼ .04). Median time to first antimicrobial administration was 43 minutes, and time to appropriate antimicrobial therapy was 1 hour, 34 minutes for the entire cohort, with pharmacist intervention decreasing the latter time significantly in patients without SSAT on initiation of the "sepsis bundle" (P < .001). Conclusion: Pharmacist assessment of patients in septic shock offers the opportunity to improve SSAT. Systems designed to use a pharmacist responder for the care of patients with septic shock maximize the selection of antimicrobials, facilitate rapid administration, and improve surrogate outcomes for mortality in septic shock.
Introduction
Sepsis affects over 700 000 Americans each year and is associated with significant morbidity and mortality. [1] [2] If unrecognized and not treated in a timely fashion, sepsis can progress to septic shock, resulting in organ dysfunction and poor patient outcomes. The Surviving Sepsis Campaign (SSC) guidelines for treatment of patients with severe sepsis and septic shock recommend initiation of appropriate, broad-spectrum antimicrobials within 1 hour of recognition. 2 This is supported by studies demonstrating an association between timely antibiotic administration and reduced mortality. 1, 3 Unfortunately, delays in antimicrobial administration are prevalent and have been documented in the literature. Kumar et al showed decreased mortality with rapid antimicrobial administration; however, the median time to antimicrobial infusion was 6 hours with <15% of patients receiving effective therapy within 1 hour of septic shock onset. 3 The task of rapid antimicrobial administration includes not only timely drug delivery but also the appropriate selection of antimicrobials. The implementation of multidisciplinary teams and protocols to treat patients with sepsis has been shown to improve time to treatment goals and reduce mortality. [4] [5] At University of Kentucky HealthCare (UK), pharmacists and pharmacy residents are members of a multidisciplinary sepsis response team, which includes overnight coverage as part of a 24-hour clinical on-call program. Pharmacists are uniquely qualified to provide a thorough assessment of patient history, previous cultures, recent antimicrobial use, and risk factors for multidrug resistant (MDR) pathogens, which are all critical components in deciding empiric antimicrobial therapy. 6 In a previous study utilizing pharmacist responders, patients with newly diagnosed sepsis treated with a multidisciplinary "sepsis bundle" were 20 times more likely to receive antibiotics within 1 hour of diagnosis than control patients (median time 0.65 hours compared to 2.4 hours). 7 However, the importance of not only rapid but appropriate antimicrobial therapy must be stressed. 8 Although previous studies have demonstrated that pharmacists may help reduce the time to first dose of broadspectrum antimicrobials (whether via individual or systemsbased interventions), no studies have evaluated the clinical role of the pharmacist on ensuring the adequacy of empiric therapy (based on the pathogen ultimately recovered) in these timesensitive emergencies. The purpose of this study was to assess the frequency and types of interventions pharmacists make regarding initial antimicrobial therapy in patients with septic shock and to determine if these interventions are associated with improved SSAT.
Materials and Methods

Setting and Patient Selection
This was a retrospective cohort study of patients diagnosed with septic shock who had a "sepsis bundle" paged out during their care. It was conducted at the University of Kentucky Chandler Medical Center (UK HealthCare), an 825-bed, level-1 trauma center that serves as a regional medical center for the state. All patients who received an order for the UK sepsis bundle from January 2012 to June 2014 were identified through a query of electronic medical records, and those with a diagnosis of septic shock were selected using Medicare Diagnosis-Related Group code 785.52 through the University HealthSystem Consortium Database. Patients were excluded for age younger than 18 years, presence of the sepsis bundle order set without initiation of new antimicrobials, discharge to hospice, culture-negative septic shock, death prior to antimicrobial initiation, and antimicrobial initiation at an outside hospital prior to patient transfer. The study was approved by the Institutional Review Board.
The UK "sepsis bundle" is an order set that can be activated at the discretion of the patient's primary clinician on suspicion of sepsis onset. The bundle includes laboratory orders for cultures, baseline chemistry, hematology, blood gas measurements, empiric antibiotics (vancomycin/pipercillintazobactam/cefepime/aztreonam), resuscitation fluids, vasoactive agents, and corticosteroids. Activation of the order set triggers an automatic notification to the pharmacy resident on-call and nursing rapid response team who will proceed to the patient's bedside to assist with assessment. During normal business hours, the patient's primary pharmacist will be notified and manage accordingly. The pharmacist responder is responsible for assessing empirically ordered antimicrobials and their appropriateness, in addition to facilitating timely delivery and administration after culture attainment. These activities can include order entry and verification, ensuring optimal doses, compounding antimicrobials at bedside retrieved from automated dispensing cabinets, and facilitating delivery to the actual bedside from floor stock or central pharmacy. The pharmacist will also help assess the patient's resuscitation status and subsequent need and preparation of vasoactive agents or corticosteroids in conjunction with the primary team. 7 Resident training for sepsis bundle response is provided during orientation via interactive lectures and simulation exercises. All pharmacist activities require documentation in the patient's electronic medical record utilizing the "Pharmacist Sepsis Response" note.
Definitions
Septic shock was defined as the presence of hypotension, despite ongoing fluid resuscitation (systolic blood pressure <90 mm Hg or mean arterial pressure < 65 mm Hg) or need for vasopressor support and was confirmed on all included patients. Data collection was performed through chart review to determine time of sepsis onset, time of initiation of antimicrobial therapy, culture data, and types of pharmacist interventions.
Time of sepsis onset with respect to antimicrobial administration (time zero) was defined as the time that the electronic sepsis bundle order set was entered. Successful selection of antimicrobial therapy (SSAT) was defined as in vitro antimicrobial activity against an isolated pathogen. Potential pathogens were identified from positive cultures obtained within 48 hours of the sepsis bundle order. Candida species isolated from respiratory and urine cultures were considered colonization unless the patient was on immunosuppressive therapy. Coagulase-negative Staphylococcus species were deemed to be a contaminant unless present in multiple blood samples. Time of antimicrobial administration was categorized in 2 ways: time to administration of first antimicrobial (defined as the first antimicrobial agent administered following activation of the sepsis bundle) and time to administration of appropriate antimicrobial therapy (defined as the time elapsed from time zero until a patient received antimicrobial therapy to cover all cultured organisms). Actual time of antimicrobial administration was determined by documented nursing administration times in the medication administration record.
Pharmacist interventions at the time of sepsis bundle order were identified through chart review of pharmacist documentation in electronic medical records or archived pharmacist oncall reports, which are sent out to the pharmacy department on a daily basis. Interventions were classified by the following: changing the originally ordered antimicrobial, adding doublecoverage for gram-negative organisms, adding antifungal coverage, or other interventions that broadened antimicrobial coverage. Pharmacist interventions were assessed with regard to SSAT and were considered a positive intervention if a change in the original antimicrobial regimen or addition of other antimicrobials resulted in coverage of a previously uncovered organism.
Outcomes
We sought to assess the frequency and types of interventions pharmacist responders make regarding initial antimicrobial therapy in septic shock and if these interventions are associated with improved SSAT. Time to initial antimicrobial therapy and time to appropriate antimicrobial therapy were also assessed. Data were tested for normality using the Shapiro-Wilk test. Normally distributed data were presented as means + standard deviation, while nonnormally distributed data were presented as medians (interquartile range), and categorical data were presented as proportions. Proportions between cohorts were compared using the chi-square or Fisher exact test. Time data were nonnormally distributed and compared between cohorts using the Mann-Whitney U test. Comparative analyses were done with SPSS v.23 (IBM, Armonk, NY).
Results
Over the 2.5-year study period, 159 sepsis bundle orders were placed. Of the 159 sepsis bundle activations, 76 patients were included in the final study cohort (Figure 1 ). Baseline demographics and clinical characteristics are reported in Table 1 . Of the included patients, the average age was 61 years old with a mean expected mortality of 31% on admission. The most common location for sepsis bundle orders was for patients in the intensive care unit (ICU; n ¼ 44 of 76, 58%). Surgical services were the highest users of the sepsis bundle order set (n ¼ 46 of 76, 60.5%). Interventions by pharmacists were documented on 35 (46%) patients, totaling 55 interventions in all. Of these interventions, the addition of double-coverage for gram-negative organisms was the most frequent ( Figure 2) . With regard to cultured organisms, gram-positive organisms, gram-negative organisms, and Candida species were isolated in 49%, 63%, and 7% of patients, respectively (percentages add up to >100% due to isolation of multiple organisms in some patients).
Regarding empiric antimicrobial coverage, at the time the sepsis bundle was activated, 50 (66%) patients had SSAT initially, while 26 (34%) patients were prescribed antimicrobials that failed to cover all cultured organisms. Of the 26 patients who did not have SSAT initially prescribed by the clinician, pharmacists intervened real time on 15 of those cases prior to the first antimicrobial dose, achieving SSAT in 11 of them ( Figure 3 ). Successful interventions that resulted in SSAT included changing the empiric antimicrobial ordered by the prescriber, adding double-coverage for gram-negative organisms or antifungal therapy, and other forms of broadening empiric coverage (eg, coverage for atypical organisms, anaerobic organisms, or resistant gram-positive organisms). This increased the overall percentage of SSAT from 66% to 80% (P ¼ .04). Twenty percent of patients still did not achieve empiric SSAT, despite pharmacist intervention in some circumstances; however, these cases mostly consisted of unusual or difficult to predict organisms such as Clostridium difficile, Stenotrophomonas maltophilia, and Candida species. Fiftyseven percent (n ¼ 20 of 35) of patients with a documented pharmacist intervention received therapy broader than necessary based on cultured organisms, the majority of which consisted of adding an aminoglycoside to double-cover gram-negative organisms (n ¼ 11 of 20, 55%). In regard to timing of antimicrobial therapy, 70% of patients (n ¼ 53 of 76) received their first antibiotic within the recommended time following septic shock diagnosis, defined as 1 hour for patients in general hospital wards and 3 hours for patients presenting through the emergency department per guideline recommendations.
2 Furthermore, 46% (n ¼ 35 of 76) received appropriate antimicrobial therapy within the goal time period with respect to cultured organisms. Median time to the first dose of antimicrobials using the pharmacist responder was 43 minutes, and median time to appropriate antimicrobial therapy was 1 hour and 34 minutes for the entire cohort. For patients with SSAT on initiation, median time to appropriate antimicrobial therapy was 1 hour and 6 minutes. Not surprisingly, time to appropriate antimicrobial therapy was longer in patients who did not have SSAT on initiation, with a median time of 4 hours and 38 minutes. This appeared to be driven by patients without documented intervention by a pharmacist and those who did not achieve empiric SSAT, despite pharmacist intervention. For those cases without SSAT initially where the pharmacist successfully intervened compared to those patients who did not achieve SSAT, the median time to appropriate antimicrobials was substantially less (2 hours and 22 minutes vs 49 hours and 10 minutes; P < .001). With regard to antimicrobial resistance, 36% (n ¼ 27 of 76) of patients in the entire cohort had a positive culture for methicillin-resistant Staphylococcus aureus (MRSA) or an organism that was not covered empirically by the beta-lactam antibiotics included in the default sepsis bundle. Fifty-six percent (n ¼ 15 out of 26) of patients lacking SSAT on initiation had an infection with a resistant organism versus 24% (n ¼ 12 of 50; P ¼ .005) of those with SSAT. Pharmacists intervened on 41% of the patients without SSAT on initiation that grew a resistant organism (n ¼ 11 of 26), achieving SSAT in 45% (n ¼ 5 of 11).
Overall mortality was comparable to the study by Kumar et al in regard to antimicrobial timing in septic shock (53%), highlighting the acuity of our patient population. 3 Median hospital and ICU length of stay were 18 and 11 days, respectively.
Discussion
In this retrospective cohort study evaluating pharmacist interventions in patients with septic shock, pharmacist intervention increased the percentage of patients with SSAT by a statistically and clinically significant margin from 66% to 80%. Given that pharmacists successfully altered empiric antimicrobial orders in 11 of 76 patients, this suggests that for every 7 patients with septic shock treated with a pharmacist responder, 1 patient will have their empiric antimicrobial orders appropriately altered to cover the culprit microorganisms (approximate number needed to treat of 7). By utilizing the pharmacist responder, time to initial antimicrobials was rapid (43 minutes). Time to appropriate antimicrobial therapy has been shown to correlate with outcomes, including mortality, in severe sepsis and septic shock. 1, 3 For patients without SSAT on initiation, time to appropriate antimicrobials was substantially shorter when the pharmacist responder intervened and adjusted antimicrobial therapy compared to those without documented intervention. Of note, there was a subset of patients who did not achieve empiric SSAT, despite pharmacist assessment. However, this was due to infection with organisms for which the patient did not have any obvious identifiable risk factors (eg, candidemia, extended-spectrum beta-lactamase-producing organism without prior history of colonization).
The benefits of inpatient clinical pharmacy services, particularly in the ICU, have been described in the literature. These include reduction in adverse drug events and medication errors, decreased drug costs, facilitation of timely drug administration, and improvement in protocol compliance during medical emergencies. [9] [10] [11] [12] [13] The Society of Critical Care Medicine views pharmacists as essential members of the multidisciplinary patient care team to ensure quality care to critically ill patients.
14 Limited literature has evaluated pharmacists' role in the management of patients with varying degrees of sepsis. Pharmacists are able to serve multiple functions when caring for patients with sepsis, including selection of empiric antimicrobial agents, optimizing loading and maintenance doses, compounding antimicrobials at the bedside and/or facilitating timely delivery, ensuring cultures are drawn prior to antimicrobial administration, recommending sequence and rate of antimicrobial administration, assisting with intravenous compatibility, and selection of vasoactive agents and/or corticosteroids as appropriate. [6] [7] Although the guidelines note that "the weight of the evidence supports prompt administration [of broad spectrum antimicrobials, i.e. within one hour of recognition] . . . the feasibility with which clinicians may achieve this ideal state has not been scientifically validated". 2(pp591-594) Our previous work using the pharmacist responder in sepsis bundle activations demonstrated one of the lowest times to antimicrobial administration in the literature (39 minutes). 7 Unfortunately, pharmacist recommendations on antimicrobial selection were not captured in that particular cohort. This study builds upon our previous data using a different cohort and demonstrates that pharmacists not only contribute to timely administration but also appropriate selection of empiric antimicrobials, optimizing the chance that causative pathogens are covered in complex, critically ill patients. Rapid time to administration was seen again in this study with time to first antimicrobial (43 minutes) and time to appropriate antimicrobials (1 hour and 34 minutes), some of the lowest times documented in the literature. By serving in these roles, pharmacists have the potential to increase institutional compliance with the current SSC guidelines and improve patient outcomes. This takes on additional importance with the development of pay-forperformance initiatives, such as the Centers for Medicare and Medicaid Services/The Joint Commission Sepsis Core Measures in the United States. 15 The compilation of the literature, including our study, suggests that pharmacists can successfully impact nearly every aspect of antimicrobial use in the care of a patient with sepsis.
Although broad-spectrum therapy against all suspected pathogens is encouraged through guideline recommendations, antimicrobial stewardship with respect to collateral damage as well as adverse effects can be of concern.
2 In our study, over one half (57%) of patients with documented pharmacist intervention received therapy that was broader than necessary based on cultured organisms. Antimicrobial stewardship is important in order to reduce antimicrobial resistance and control drug costs; yet, it is well documented that failure to initiate appropriate antimicrobial therapy in a timely fashion correlates with increased mortality in patients with severe sepsis and septic shock, indicating that a conservative approach is not an ideal strategy in this patient population. [1] [2] [3] 8, 16 This was initially demonstrated by Kumar et al, who showed a mortality increase by 7.6% for each hour delay in administration of appropriate antimicrobials following the diagnosis of septic shock, and then by Gaieski et al, who showed significantly lower in-hospital mortality in patients who received appropriate antibiotics within 1 hour of presentation to the ED. 3, 8 In a more recent study by Ferrer et al, the authors confirmed a linear increase in mortality when antibiotics were initiated from zero to greater than 6 hours from diagnosis of severe sepsis or septic shock. Unlike previous studies, this was consistent across all hospital locations and levels of acuity.
1 Although some authors have recently challenged the survival benefit of early antimicrobial administration in sepsis, the appropriateness of antimicrobial therapy was not assessed and timing would not be expected to alter patient prognosis if the causative organism is not covered. [17] [18] Thus, the previous, larger body of evidence supports the standard guideline approach to treating patients with severe sepsis and septic shock of initiating timely, broad-spectrum antimicrobial coverage tailored to the patient's risk factors for specific pathogens, followed by de-escalation as culture data becomes available. 2 MDR organisms are important factors that increase a patient's risk for inappropriate empiric antimicrobial therapy, particularly gram-negative organisms, whose rates of resistance have been on the rise. 19, 20 Pathogens such as MDR Pseudomonas and carbapenem-resistant Enterobacteriaceae can pose a significant impact on mortality. In a study conducted by Zilberberg et al aiming to determine the impact of initially inappropriate antibiotic therapy on mortality in patients with severe sepsis and septic shock due to gram-negative organisms, nonsurvivors were significantly more likely to be culture positive for an MDR organism than survivors (10% vs 4%). Nonsurvivors also had a significantly higher likelihood of receiving initially inappropriate therapy (43% vs 15%). 16 Similar differences were noted in our study with regard to resistant organisms and the likelihood of receiving SSAT on initiation. Pharmacists intervened on close to half of the patients without SSAT initially that ultimately grew a resistant organism, achieving SSAT in 45% of patients who otherwise would have had inadequate empiric coverage. This further supports the need for a multidisciplinary approach involving a clinical pharmacist in assisting with the selection of empiric antimicrobial therapy in patients with septic shock.
While our study demonstrates a substantial impact of pharmacist involvement in septic shock management, it is not without limitations. The clinical impact of pharmacists improving SSAT was not assessed. However, given the existing data, proper selection and timing of antimicrobial administration are appropriate surrogate end points to assess the impact of pharmacist responders, as they have been associated with mortality in septic shock. Although such interventions occur in routine clinical practice, we also did not capture pharmacy intervention when it came to loading doses and appropriate dosing of antimicrobials. Excluding culture-negative patients with septic shock eliminated a fair number of patients, but it would have been challenging to objectively identify an appropriate intervention without definitive culture results. It must also be noted that the logistics of the sepsis response structure used at our hospital may not translate exactly as described in this report to every institution. Our hospital has a licensed pharmacist on-call every hour of the year. While a 24-hour on-call program may not be feasible at every institution, incorporating existing critical care pharmacists and other clinical pharmacists-as cross-training and work flow allows-into the sepsis response team may allow for improved antimicrobial selection and timing in patients with septic shock. At minimum, we have demonstrated that a careful review of empirically ordered antimicrobials by a pharmacist is likely to ensure that 42 of 100 patients in septic shock originally prescribed inadequate therapy will be changed to appropriate therapy. We revealed a fairly high percentage of resistant organisms (36%), increasing the need for pharmacist assessment to recommend broader antimicrobial therapy or double-coverage as appropriate. For centers with a low prevalence of MDR organisms, pharmacists may still play an important role in working with multidisciplinary teams to optimize antimicrobial dosing and facilitate rapid delivery and administration; however, their impact on appropriate selection may be less pronounced. Finally, pharmacist interventions were captured via existing documentation only; thus, the true intervention rate and impact on SSAT may be even higher as some pharmacists may have failed to provide documentation in the medical record.
Conclusion
This study demonstrates that interventions by pharmacist responders are associated with improved SSAT upon initiation of antimicrobial therapy in the "golden hour" of septic shock. With the increasing prevalence of MDR organisms, an educated and guided approach to empiric antimicrobial selection will continue to gain importance. Including pharmacists in the multidisciplinary approach to patients with varying degrees of sepsis has the potential to improve selection and timing of empiric antimicrobial therapy, ultimately impacting patient outcomes.
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